Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleInitial Results of MCRN 009: Phase 2 Study of an Accelerated Infusion Rate of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma (MM).AuthorsStakiw, Julie; Kukreti, Vishal; LeBlanc, Richard; Sebag, Michael; Hay, Annette; Cote, Julie; Camacho, Fernando; Gul, Engin; Reece, DonnaPublicationClinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pe259ISSN2152-2650Publication typeArticleDOI10.1016/j.clml.2019.09.428